A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia

PHASE2RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

April 3, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions

Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)

Interventions

DRUG

HRS-8427

HRS-8427 for injection.

DRUG

Meropenem

Meropenem for injection.

Trial Locations (1)

RECRUITING

China-Japan Friendship Hospital, Beijing

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY